Intraperitoneal oxidative stress as an oncolytic immunomodulator?
Michael Bette1, Robert Mandic2
1Department of Molecular Neuroscience, Institute of Anatomy and Cell Biology, Philipps University , Marburg, Germany.
Oncoimmunology
|May 6, 2015
Summary
Intraperitoneal oxidative stress transforms the immune response against rabbit VX2 carcinoma. This approach generates a lasting tumor-killing immune effect that can be transferred to other hosts.
Area of Science:
- Oncology
- Immunology
- Virology
Background:
- The rabbit VX2 carcinoma, associated with papillomavirus, typically evades the immune system.
- Tumor-permissive immune responses hinder effective cancer treatment.
Purpose of the Study:
- To investigate if inducing intraperitoneal oxidative stress can alter the immune microenvironment.
- To determine if this alteration can convert the immune response from tumor-permissive to tumoricidal against VX2 carcinoma.
- To assess the potential for a sustainable, transferable oncolytic immune response.
Main Methods:
- Induction of oxidative stress in the peritoneal cavity of rabbits bearing VX2 carcinoma.
- Analysis of immune cell populations and cytokine profiles within the tumor microenvironment.
- Evaluation of tumor growth and regression post-treatment.
- Assessment of adoptive transfer of immune cells from treated to naive rabbits.
Main Results:
- Intraperitoneal oxidative stress significantly shifted the immune response towards a tumoricidal phenotype.
- A robust and sustainable oncolytic immune response was generated.
- Immune cells from treated rabbits demonstrated the ability to inhibit tumor growth upon adoptive transfer.
Conclusions:
- Intraperitoneal oxidative stress is a viable strategy to re-educate the immune system against papillomavirus-associated tumors.
- This method establishes a durable, transferable anti-tumor immunity.
- Oxidative stress induction offers a novel therapeutic avenue for oncolytic immunotherapy.
More Related Videos
Related Concept Videos
02:49Cancer Therapies
10.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.7K
01:27Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
01:46Electron Transport Chain: Complex I and II
19.7K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.7K